Home » EU Regulator Adopts Plan for Biosimilar Antibodies
EU Regulator Adopts Plan for Biosimilar Antibodies
European regulators adopted a new guideline on so-called biosimilar antibody drugs, paving the way for cheaper copies of multi-billion-dollar medicines used to treat cancer and other serious diseases.
XE
XE
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May